查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1564957

高解析度熔化分析的全球市場

High-Resolution Melting Analysis
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球高解析度熔化分析市場預計將達到 4.192 億美元

高解析度熔化分析的全球市場預計 2023 年為 3.438 億美元，預計到 2030 年將達到 4.192 億美元，2023 年至 2030 年複合年成長率為 2.9%。其他應用程式是本報告分析的細分市場之一，預計複合年成長率為 1.4%，到分析期結束時將達到 3,110 萬美元。在分析期間，表觀遺傳學應用領域的複合年成長率預計為 1.7%。

美國市場預估為9,250萬美元，中國預期複合年成長率為2.7%

預計 2023 年美國高解析度熔化分析市場規模將達到 9,250 萬美元。中國作為世界第二大經濟體，預計到 2030 年市場規模將達到 6,710 萬美元，2023-2030 年分析期間複合年成長率為 2.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.7% 和 2.3%。在歐洲，德國的複合年成長率預計為 3.2%。

全球高解析度熔化分析市場－主要趨勢與促進因素總結

高解析度熔解分析 (HRM) 是現代分子診斷中快速且準確的基因組分析的關鍵嗎？

高解析度熔解 (HRM) 分析正在徹底改變分子診斷和基因研究，但為什麼這種方法在現代實驗室中如此重要？ HRM 是一種聚合酵素鏈鎖反應(PCR) 後分析技術，用於識別 DNA 中的遺傳變異，例如單核苷酸多態性 (SNP)、突變和甲基化差異。透過監測雙鏈DNA 解離成單鏈時的精確熔解行為，HRM 提供了一種快速、高通量的方法來檢測 DNA 序列的細微變化。它廣泛應用於醫學診斷、基因研究、表觀遺傳學研究和病原體檢測，為繁瑣的定序方法提供了一種經濟、準確、高效的替代方案。

HRM 的吸引力在於它可以以最少的設置和成本提供詳細的基因組資訊。 HRM 速度快、可擴展且可自動化，非常適合需要快速結果的應用，例如臨床環境、癌症研究和農業生物技術。 HRM 具有高度敏感性，甚至可以檢測最輕微的基因突變，這使其可用於識別致病突變、監測抗藥性和檢驗遺傳標記。隨著基因組研究和精準醫學的不斷擴展，HRM 在推動分子診斷和個人化醫療保健方面發揮越來越重要的作用。

高解析度熔化分析技術如何進步

技術進步顯著提高了高解析度熔解分析的靈敏度、準確性和效率，使其成為遺傳和診斷應用中更易於使用和更強大的工具。主要發展之一是開發了具有高解析度光學和溫度控制功能的更精確的即時PCR儀器。這些儀器能夠高精度地精確測量 DNA 熔解曲線，甚至可以檢測 DNA 序列中最細微的差異。聚合酵素連鎖反應熱迴圈儀的改進可以更好地控制溫度變化。這對於創建可重複的、高解析度的熔解曲線來區分密切相關的遺傳變異至關重要。

專為 HRM 設計的嵌入染料的引入也提高了該技術的準確性和性能。用於 DNA 擴增的傳統螢光染料（例如 SYBR Green）檢測微小序列變異的能力有限。 LCGreen 和 EvaGreen 等新型染料能夠更選擇性地與雙鏈DNA 結合，並產生更穩定的螢光訊號，更容易辨別與微小基因變化相關的解鏈溫度變化。這些染料提高了 HRM 的靈敏度，可以更清楚地檢測雜合突變、SNP 和甲基化差異。

HRM 分析軟體的進步進一步最佳化了複雜熔化曲線的解釋。現代 HRM 軟體旨在更準確地分析熔解曲線，使研究人員可以透過將實驗資料與已知的參考曲線進行比較來檢測和量化微小的遺傳差異。這些演算法可以自動同時分析多個熔解曲線、辨識模式，甚至在實驗過程中提供即時回饋。機器學習和人工智慧主導的分析工具的整合將增強 HRM 識別遺傳資料細微差別的能力，增加對結果的信心，並使該技術對臨床和研究應用更加方便用戶使用。

此外，多重功能允許在單一反應中同時分析多個位點或樣本，從而提高了 HRM 的效用。借助最佳化的引子設計和染料選擇，HRM 現在可用於在單次運行中區分多個靶標，從而提高通量並降低成本。這項進展在臨床診斷中特別有用，其中快速檢測患者樣本中的多種突變和遺傳標記對於診斷疾病、監測治療反應和識別抗藥性病原體至關重要。多重HRM也提高了基因篩檢計劃的效率，允許以時間和成本效益高的方式分析大量人口的特定遺傳變異。

隨著 HRM 與次世代定序(NGS) 技術的日益整合，HRM 在基因組學研究中的作用正在擴大。儘管 HRM 是一種快速且經濟高效的篩檢工具，但它擴大與 NGS 結合使用，用於在定序前對樣品進行確認和預篩檢。 HRM 可以快速識別具有已知突變或變異的樣本，從而減少對全基因組進行大規模定序的需求。這種方法簡化了遺傳分析過程，節省了研究和臨床應用的時間和資源。 HRM 在大規模遺傳研究中特別有用，研究人員需要快速識別候選樣本以進行更詳細的定序。

此外，HRM 在甲基化分析方面的應用也得到了改進，這對於表觀遺傳學研究至關重要。 DNA甲基化在基因調控中發揮重要作用，並與包括癌症在內的多種疾病有關。甲基化敏感HRM (MS-HRM) 可以透過利用解鏈行為的差異來區分甲基化和非甲基化DNA 區域，使其成為表觀遺傳分析的快速方法，提供了一種獨特的非基於序列的方法。因此，HRM 已成為了解表觀遺傳修飾在基因表現和疾病發展中的作用的重要工具，特別是在腫瘤學中。

為什麼高解析度熔解分析對於現代分子診斷和研究至關重要？

高解析度熔解分析是現代分子診斷中的一項新興技術，因為它提供了一種快速、準確且經濟有效的檢測遺傳變異的方法，這對於了解疾病、抗藥性和遺傳疾病至關重要，並且對於研究極為重要。在臨床診斷中，HRM 用於識別與囊腫纖維化、鐮狀性貧血和地中海貧血等遺傳性疾病相關的基因突變。可以檢測單核苷酸多態性（SNP）和其他細微的遺傳變化，使其成為篩檢患者致病突變和識別遺傳性疾病攜帶者的理想目標。這在產前和新生兒篩檢中尤其重要，早期發現遺傳異常可以指南醫療干預並改善患者的治療結果。

HRM 的重要性延伸到癌症診斷和個人化醫療，而識別 BRCA1、KRAS 和 EGFR 等癌症相關基因的特定突變對於確定最有效的治療策略至關重要。 HRM 可以快速檢測已知和新的突變，這些突變會影響癌症進展和患者對標靶治療的反應。透過快速識別可操作的突變，HRM 支持不斷發展的精準腫瘤學領域，該領域根據個體腫瘤的遺傳特徵量身定做治療方案。隨著時間的推移監測腫瘤突變的能力，特別是對治療的反應，將使更個人化和適應性的癌症治療成為可能，並改善患者的治療結果。

在感染疾病診斷中，HRM 在檢測病原體突變方面發揮著至關重要的作用，特別是在抗藥性的背景下。例如，HRM 可用於檢測細菌、病毒和真菌中導致抗病毒藥物和抗真菌藥物抗藥性的基因突變。快速檢測此類抗藥性對於確定適當的治療策略至關重要，特別是當抗藥性導致治療失敗時。 HRM 已用於檢測與抗生素抗藥性結核分枝桿菌菌株、HIV 抗藥性和流感變異相關的突變，從而能夠及時做出明智的治療方法決策。

HRM 在農業生物技術中也很有用，可用於遺傳標記分析和植物育種計劃。在作物育種中，HRM 允許研究人員透過識別與這些性狀相關的遺傳變異來篩檢所需的性狀，例如抗病性、耐旱性和產量。 HRM 在標記輔助選擇中特別有用，可以幫助育種者快速識別具有優勢遺傳性狀的植物，並加速改良作物品種的開發。此外，HRM 也用於檢測基因改造作物(GMO)，透過識別與基因改造相關的特定 DNA 序列，確保作物符合監管和安全標準。

在表觀遺傳學領域，HRM 對於理解 DNA 甲基化模式如何影響基因表現和疾病至關重要。 DNA甲基化的變化與多種疾病有關，包括癌症、自體免疫疾病和神經系統疾病。 HRM 可以快速有效地分析甲基化模式，使其成為研究疾病進展和治療反應中表觀遺傳學變化的重要工具。例如，在癌症研究中，HRM 用於檢測抑癌基因的高甲基化。這可能導致通常阻止不受控制的細胞生長的基因定序。

HRM 可以快速篩檢大量人群的遺傳變異，使其成為群體遺傳學和流行病學研究的寶貴工具。透過識別人群中的 SNP 和其他遺傳標記，研究人員可以更好地了解疾病的遺傳基礎、追蹤遺傳性狀的傳播或監測病原體的進化。 HRM 的高通量能力和相對較低的成本使其特別適合大規模遺傳研究，其中資料分析和解釋需要快速識別遺傳變異。

推動高解析度熔化分析市場成長的因素有哪些？

高解析度熔解(HRM) 分析市場的成長受到多種因素的推動，包括對快速且具有成本效益的基因檢測的需求不斷成長、對精準醫療的需求不斷成長、分子診斷的進步以及基因組學作用的不斷擴大這是由幾個重要因素造成的。主要促進因素之一是醫療保健領域對基因檢測的需求不斷成長，HRM 提供了一種快速、準確的方法來識別基因突變、SNP 和表觀遺傳學變化。隨著基因檢測融入常規醫療保健，特別是癌症診斷、新生兒篩檢和產前檢測，HRM 為臨床醫生和實驗室提供了可擴展且負擔得起的解決方案。

全球向個人化醫療的轉變也是人力資源管理市場的主要驅動力。特別是在腫瘤學領域，隨著越來越多的治療方法根據患者的基因組成量身定做，對能夠快速、準確地檢測基因突變的工具的需求不斷成長。 HRM 非常適合滿足這一需求，因為它允許臨床醫生快速識別可操作的突變，從而為治療決策提供資訊、監測治療反應並追蹤抗藥性的出現。 HRM 即時快速分析遺傳資料的能力是個人化醫療保健的重要工具，及時介入對於患者的治療結果至關重要。

PCR 儀器、染料和分析軟體的技術進步進一步提高了 HRM 的效用，並使包括小型實驗室和診所在內的廣大用戶更容易使用它。更靈敏的嵌入染料、更好的聚合酵素連鎖反應熱迴圈儀和改進的資料分析軟體的開發提高了 HRM 的準確性和解析度，使其成為與定序等昂貴且費力的技術相比的競爭者。這些創新使 HRM 成為從臨床診斷到農業研究等廣泛應用的實用選擇，並且擴大在各個領域中被採用。

遺傳和表觀遺傳研究在理解複雜疾病方面日益重要，也刺激了對人力資源管理的需求。研究人員擴大使用 HRM 來研究導致癌症、心血管疾病和神經系統疾病等疾病的基因突變、表觀遺傳修飾和基因表現模式。 HRM 提供了一種高通量、經濟高效的方法來篩檢大量樣本，使其成為需要分析大量遺傳標記的研究的理想選擇。隨著基因組學和表觀遺傳學研究的不斷擴展，HRM 將繼續成為闡明健康和疾病分子機制的寶貴工具。

在病原體檢測和抗藥性監測中增加HRM的使用也是推動市場成長的關鍵因素。由於全球衛生界面臨抗生素抗藥性、新出現的病毒威脅以及對快速診斷工具的需求等挑戰，HRM 是檢測與抗藥性相關的病原體進化和突變的可靠且有效的方法。 HRM 能夠快速識別導致抗藥性的基因突變，使醫療保健提供者能夠就治療策略做出更明智的決策，減少抗藥性菌株的傳播，並改善患者的治療效果。

最後，與次世代定序(NGS) 等複雜技術相比，HRM 價格實惠且易於使用，這使其成為臨床和研究實驗室的有吸引力的選擇。 HRM 為預先篩檢檢體和確認其他基因檢測方法所獲得的結果提供了一種經濟高效的解決方案，使其成為 NGS 和其他高通量技術的寶貴補充。這種經濟性與高靈敏度和準確性的結合使其在世界各地的實驗室中得到採用，特別是在快速週轉和成本控制至關重要的地方。

由於分子診斷的進步、個人化醫療需求的增加以及遺傳和表觀遺傳研究在醫療保健中作用的擴大，高解析度熔解分析市場有望顯著成長。隨著基因組學不斷革新醫學，HRM 將繼續成為快速且準確地檢測遺傳變異、指導治療決策和推進疾病分子基礎研究的重要工具。

受訪企業範例（共12家）

  • Agilent Technologies, Inc.
  • Azura Genomics Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Canon Biomedical Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Meridian Bioscience, Inc.
  • Premier Biosoft International
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP12402

Global High-Resolution Melting Analysis Market to Reach US$419.2 Million by 2030

The global market for High-Resolution Melting Analysis estimated at US$343.8 Million in the year 2023, is expected to reach US$419.2 Million by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Other Applications, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$31.1 Million by the end of the analysis period. Growth in the Epigenetics Application segment is estimated at 1.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$92.5 Million While China is Forecast to Grow at 2.7% CAGR

The High-Resolution Melting Analysis market in the U.S. is estimated at US$92.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$67.1 Million by the year 2030 trailing a CAGR of 2.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global High-Resolution Melting Analysis Market - Key Trends and Drivers Summarized

Is High-Resolution Melting Analysis (HRM) the Key to Rapid and Accurate Genomic Profiling in Modern Molecular Diagnostics?

High-Resolution Melting (HRM) analysis is revolutionizing molecular diagnostics and genetic research, but why is this method so crucial in modern laboratories? HRM is a post-PCR (Polymerase Chain Reaction) analysis technique used to identify genetic variations, such as single nucleotide polymorphisms (SNPs), mutations, or methylation differences in DNA. By monitoring the precise melting behavior of double-stranded DNA as it dissociates into single strands, HRM provides a rapid, high-throughput method for detecting subtle changes in DNA sequences. It is widely used in medical diagnostics, genetic research, epigenetic studies, and pathogen detection, offering a cost-effective, accurate, and efficient alternative to more labor-intensive sequencing methods.

The appeal of HRM lies in its ability to provide detailed genomic information with minimal setup and cost. HRM is fast, scalable, and can be automated, making it ideal for applications where rapid results are essential, such as in clinical settings, cancer research, and agricultural biotechnology. HRM’s sensitivity in detecting even minor genetic variations makes it a powerful tool for identifying disease-causing mutations, monitoring drug resistance, and validating genetic markers. As genomic research and precision medicine continue to expand, HRM is playing an increasingly pivotal role in advancing molecular diagnostics and personalized healthcare.

How Has Technology Advanced High-Resolution Melting Analysis?

Technological advancements have significantly improved the sensitivity, accuracy, and efficiency of High-Resolution Melting analysis, making it a more accessible and powerful tool for genetic and diagnostic applications. One of the key advancements has been in the development of more precise real-time PCR machines equipped with high-resolution optics and temperature control. These machines can accurately measure the melting curves of DNA with high precision, allowing for the detection of even the most subtle differences in DNA sequences. Improvements in thermal cyclers have enabled finer control over temperature changes, which is critical for generating reproducible and high-resolution melting profiles that differentiate between closely related genetic variants.

The introduction of intercalating dyes specifically designed for HRM has also enhanced the accuracy and performance of the technique. Traditional fluorescent dyes, such as SYBR Green, used in DNA amplification had limitations in detecting minor sequence variations. Newer dyes, like LCGreen and EvaGreen, bind more selectively to double-stranded DNA and produce more consistent fluorescence signals, enabling better discrimination of melting temperature shifts associated with small genetic changes. These dyes improve the sensitivity of HRM, making it possible to detect heterozygous mutations, SNPs, and methylation differences with greater clarity.

Advances in software for HRM analysis have further optimized the interpretation of complex melting profiles. Modern HRM software is designed to analyze melting curves with greater precision, allowing researchers to detect and quantify small genetic differences by comparing experimental data against known reference curves. These algorithms can automatically analyze multiple melting curves simultaneously, identify patterns, and even provide real-time feedback during an experiment. The integration of machine learning and AI-driven analysis tools has enhanced the ability of HRM to identify subtle variations in genetic data, improving the reliability of results and making the technique more user-friendly for both clinical and research applications.

Multiplexing capabilities have also improved the utility of HRM by enabling the simultaneous analysis of multiple genetic loci or samples in a single reaction. With the help of optimized primer design and dye selection, HRM can now be used to differentiate between multiple targets in a single run, increasing throughput and reducing costs. This advancement is particularly valuable in clinical diagnostics, where rapid detection of multiple mutations or genetic markers in a patient sample is critical for diagnosing diseases, monitoring treatment responses, or identifying drug-resistant pathogens. Multiplexed HRM also improves efficiency in genetic screening programs, where large populations can be analyzed for specific genetic variations in a time- and cost-efficient manner.

The growing integration of HRM with next-generation sequencing (NGS) technologies has expanded its role in genomics research. While HRM offers a rapid and cost-effective screening tool, it is increasingly used in conjunction with NGS to confirm or pre-screen samples before sequencing. HRM can quickly identify samples with known mutations or variations, reducing the need for extensive sequencing of entire genomes. This approach streamlines the genetic analysis process, saving time and resources in both research and clinical applications. HRM is particularly useful in large-scale genetic studies, where researchers need to quickly identify candidate samples for more in-depth sequencing.

Moreover, HRM has seen improvements in its application for methylation analysis, which is crucial for epigenetic studies. DNA methylation plays a significant role in gene regulation and has been implicated in various diseases, including cancer. Methylation-sensitive HRM (MS-HRM) allows researchers to differentiate between methylated and unmethylated DNA regions by exploiting differences in melting behavior, providing a rapid, non-sequencing-based method for epigenetic analysis. This makes HRM an essential tool for understanding the role of epigenetic modifications in gene expression and disease development, particularly in oncology.

Why Is High-Resolution Melting Analysis Critical for Modern Molecular Diagnostics and Research?

High-Resolution Melting analysis is critical for modern molecular diagnostics and research because it offers a rapid, accurate, and cost-effective method for detecting genetic variations, which are often the key to understanding diseases, drug resistance, and genetic disorders. In clinical diagnostics, HRM is used to identify mutations in genes associated with inherited diseases, such as cystic fibrosis, sickle cell anemia, and thalassemia. Its ability to detect single nucleotide polymorphisms (SNPs) and other minor genetic changes makes it ideal for screening patients for disease-causing mutations or identifying carriers of genetic disorders. This is particularly important in prenatal and newborn screening, where early detection of genetic abnormalities can guide medical interventions and improve patient outcomes.

HRM’s importance extends to cancer diagnostics and personalized medicine, where identifying specific mutations in cancer-related genes, such as BRCA1, KRAS, or EGFR, is crucial for determining the most effective treatment strategy. HRM is capable of rapidly detecting both known and novel mutations that can influence cancer progression or a patient’s response to targeted therapies. By enabling the quick identification of actionable mutations, HRM supports the growing field of precision oncology, where treatments are tailored to the genetic profile of an individual’s tumor. The ability to monitor tumor mutations over time, particularly in response to treatment, allows for more personalized and adaptive cancer care, improving outcomes for patients.

In infectious disease diagnostics, HRM plays a pivotal role in detecting pathogen mutations, particularly in the context of drug resistance. For example, HRM can be used to detect mutations in the genes of bacteria, viruses, or fungi that confer resistance to antibiotics, antivirals, or antifungal agents. This rapid detection of drug resistance is crucial in guiding appropriate treatment decisions, particularly in cases where resistance can lead to treatment failure. HRM has been used to detect mutations associated with antibiotic-resistant tuberculosis strains, HIV drug resistance, and influenza variants, enabling timely and informed decisions on treatment options.

HRM is also valuable in agricultural biotechnology, where it is used for genetic marker analysis and plant breeding programs. In crop improvement, HRM allows researchers to screen for desirable traits, such as disease resistance, drought tolerance, or higher yield potential, by identifying genetic variations linked to these traits. HRM is particularly useful in marker-assisted selection, where it helps breeders quickly identify plants with favorable genetic traits, accelerating the development of improved crop varieties. In addition, HRM is used to detect genetically modified organisms (GMOs) by identifying specific DNA sequences associated with genetic modifications, ensuring that crops meet regulatory and safety standards.

In the field of epigenetics, HRM is critical for understanding how DNA methylation patterns influence gene expression and disease. Changes in DNA methylation are associated with various diseases, including cancer, autoimmune disorders, and neurological conditions. HRM provides a rapid and efficient method for analyzing methylation patterns, making it an important tool for studying epigenetic changes in disease progression and response to therapy. In cancer research, for example, HRM is used to detect hypermethylation of tumor suppressor genes, which can lead to the silencing of genes that normally prevent uncontrolled cell growth.

The ability of HRM to quickly screen large populations for genetic variations makes it a valuable tool in population genetics and epidemiological studies. By identifying SNPs or other genetic markers across populations, researchers can better understand the genetic basis of diseases, track the spread of genetic traits, or monitor the evolution of pathogens. HRM’s high-throughput capability and relatively low cost make it particularly well-suited for large-scale genetic studies, where the rapid identification of genetic variations is necessary for data analysis and interpretation.

What Factors Are Driving the Growth of the High-Resolution Melting Analysis Market?

The growth of the High-Resolution Melting (HRM) analysis market is driven by several key factors, including the increasing demand for rapid and cost-effective genetic testing, the growing need for precision medicine, advancements in molecular diagnostics, and the expanding role of genomics in disease research. One of the primary drivers is the rising demand for genetic testing in healthcare, where HRM provides a fast and accurate method for identifying genetic mutations, SNPs, and epigenetic changes. As genetic testing becomes more integrated into routine healthcare, particularly in cancer diagnostics, newborn screening, and prenatal testing, HRM offers a scalable and affordable solution for clinicians and laboratories.

The global shift toward personalized medicine is also a major driver of the HRM market. As more therapies, especially in oncology, are tailored to the genetic makeup of patients, the need for tools that can rapidly and accurately detect genetic mutations is increasing. HRM is well-positioned to meet this demand because it allows clinicians to quickly identify actionable mutations that inform treatment decisions, monitor treatment response, and track the emergence of drug resistance. The ability to rapidly analyze genetic data in real time makes HRM an essential tool in personalized healthcare, where timely intervention is critical for patient outcomes.

Technological advancements in PCR instruments, dyes, and analytical software have further enhanced the utility of HRM, making it more accessible to a broader range of users, including smaller laboratories and clinics. The development of more sensitive intercalating dyes, better thermal cyclers, and improved data analysis software has increased the accuracy and resolution of HRM, allowing it to compete with more expensive and labor-intensive techniques like sequencing. These innovations have made HRM a practical choice for a wide range of applications, from clinical diagnostics to agricultural research, driving its adoption across multiple sectors.

The growing importance of genetic and epigenetic research in understanding complex diseases is also fueling the demand for HRM. Researchers are increasingly using HRM to study genetic variations, epigenetic modifications, and gene expression patterns that contribute to diseases such as cancer, cardiovascular conditions, and neurological disorders. HRM provides a high-throughput, cost-effective method for screening large numbers of samples, making it ideal for research studies that require the analysis of many genetic markers. As research in genomics and epigenetics continues to expand, HRM will remain a valuable tool for uncovering the molecular mechanisms underlying health and disease.

The increasing use of HRM in pathogen detection and monitoring drug resistance is another key factor driving market growth. As the global health community faces challenges such as antibiotic resistance, emerging viral threats, and the need for rapid diagnostic tools, HRM offers a reliable and efficient method for detecting mutations associated with pathogen evolution and resistance. HRM’s ability to quickly identify mutations in genes responsible for drug resistance enables healthcare providers to make more informed decisions about treatment strategies, reducing the spread of resistant strains and improving patient outcomes.

Lastly, the affordability and ease of use of HRM compared to more complex techniques like next-generation sequencing (NGS) have made it an attractive option for both clinical and research laboratories. HRM offers a cost-effective solution for pre-screening samples or confirming results obtained from other genetic testing methods, making it a valuable complement to NGS and other high-throughput technologies. This affordability, combined with its high sensitivity and accuracy, is driving its adoption in laboratories worldwide, particularly in settings where rapid turnaround and cost control are critical.

With advancements in molecular diagnostics, the growing demand for personalized medicine, and the expanding role of genetic and epigenetic research in healthcare, the High-Resolution Melting analysis market is poised for significant growth. As genomics continues to revolutionize medical science, HRM will remain an essential tool for quickly and accurately detecting genetic variations, guiding treatment decisions, and advancing research into the molecular basis of disease.

Select Competitors (Total 12 Featured) -

  • Agilent Technologies, Inc.
  • Azura Genomics Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Canon Biomedical Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Meridian Bioscience, Inc.
  • Premier Biosoft International
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • High-Resolution Melting Analysis - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growth in Oncology and Genetic Testing Expands Addressable Market for High-Resolution Melting Analysis
    • Role of High-Resolution Melting Analysis in Enhancing Genotyping Accuracy and Speed Strengthens Business Case
    • Growth in Use of HRM Analysis in Infectious Disease Diagnostics Expands Market Opportunities
    • Expansion of High-Resolution Melting Analysis in Pharmacogenomics Drives Market Growth
    • Role of HRM in Supporting Clinical Trials and Drug Development Expands Addressable Market
    • Increasing Focus on Non-invasive Prenatal Testing (NIPT) Expands Adoption of High-Resolution Melting Analysis
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World High-Resolution Melting Analysis Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for High-Resolution Melting Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for High-Resolution Melting Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for SNP Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for SNP Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for SNP Genotyping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Mutation Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Mutation Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Mutation Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Species Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Species Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Species Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pathogen Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pathogen Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pathogen Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • JAPAN
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • CHINA
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • EUROPE
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for High-Resolution Melting Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for High-Resolution Melting Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • FRANCE
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • GERMANY
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030

IV. COMPETITION